DAPIZO TAB 10'S

About

DAPIZO TAB is an oral antidiabetic medication belonging to the class of Sodium-Glucose Co-transporter 2 (SGLT2) inhibitors. Its active ingredient, likely Dapagliflozin, works by blocking the reabsorption of glucose in the kidneys, leading to increased glucose excretion in the urine. This mechanism is independent of insulin secretion and sensitivity, making it effective in lowering blood glucose levels in patients with Type 2 Diabetes Mellitus. Beyond glycemic control, DAPIZO TAB has demonstrated additional benefits, including weight reduction and a decrease in blood pressure. It is indicated as an adjunct to diet and exercise to improve glycemic control in adults with Type 2 Diabetes. Furthermore, some SGLT2 inhibitors have shown cardiovascular and renal protective effects, making them valuable in managing the broader spectrum of diabetic complications. It represents a modern approach to diabetes management.

Uses

• Management of Type 2 Diabetes Mellitus
• To improve glycemic control in adults
• As an adjunct to diet and exercise
• To reduce risk of cardiovascular events (for some SGLT2 inhibitors)

Directions For Use

Take this medication orally, usually once daily in the morning, with or without food, as directed by your physician. Swallow the tablet whole with water.

Benefits

• Effective blood sugar lowering
• Insulin-independent mechanism
• Promotes weight loss
• May lower blood pressure
• Reduced HbA1c levels
• Potential cardiovascular and renal benefits

Side Effects

• Urinary tract infections (UTIs)
• Genital yeast infections
• Increased urination
• Thirst
• Dizziness
• Hypotension (low blood pressure)
• Ketoacidosis (rare but serious)
• Kidney problems (acute)
• Back pain
• Flu-like symptoms
• Nausea
• Fatigue

Safety Measures

• Alcohol - Limit alcohol intake as it can increase the risk of dehydration and ketoacidosis, especially with SGLT2 inhibitors.
• Pregnancy - Not recommended during pregnancy, especially in the second and third trimesters. Consult your doctor.
• Breastfeeding - Not advised during breastfeeding as it may pass into breast milk and harm the infant. Consult your doctor.
• Liver - Generally safe, but use with caution in severe hepatic impairment. No dose adjustment typically needed for mild to moderate.
• Kidney - Not recommended in severe kidney impairment (eGFR below a certain threshold) due to reduced efficacy and potential risks.
• Lung - No specific contraindication for lung conditions.

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.